694 related articles for article (PubMed ID: 17510462)
1. Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet.
Harrington SC; Simari RD; Conover CA
Circ Res; 2007 Jun; 100(12):1696-702. PubMed ID: 17510462
[TBL] [Abstract][Full Text] [Related]
2. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
[TBL] [Abstract][Full Text] [Related]
3. Progression of atherosclerosis in ApoE-deficient mice that express distinct molecular forms of TNF-alpha.
Canault M; Peiretti F; Poggi M; Mueller C; Kopp F; Bonardo B; Bastelica D; Nicolay A; Alessi MC; Nalbone G
J Pathol; 2008 Apr; 214(5):574-83. PubMed ID: 18247429
[TBL] [Abstract][Full Text] [Related]
4. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
[TBL] [Abstract][Full Text] [Related]
5. Transgenic overexpression of pregnancy-associated plasma protein-A in murine arterial smooth muscle accelerates atherosclerotic lesion development.
Conover CA; Mason MA; Bale LK; Harrington SC; Nyegaard M; Oxvig C; Overgaard MT
Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H284-91. PubMed ID: 20472761
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications.
Chi H; Messas E; Levine RA; Graves DT; Amar S
Circulation; 2004 Sep; 110(12):1678-85. PubMed ID: 15353494
[TBL] [Abstract][Full Text] [Related]
7. The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.
Eto H; Miyata M; Shirasawa T; Akasaki Y; Hamada N; Nagaki A; Orihara K; Biro S; Tei C
Hypertens Res; 2008 Aug; 31(8):1631-42. PubMed ID: 18971539
[TBL] [Abstract][Full Text] [Related]
8. Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice.
Iwai M; Chen R; Li Z; Shiuchi T; Suzuki J; Ide A; Tsuda M; Okumura M; Min LJ; Mogi M; Horiuchi M
Circulation; 2005 Sep; 112(11):1636-43. PubMed ID: 16145000
[TBL] [Abstract][Full Text] [Related]
9. Total panax notoginsenosides prevent atherosclerosis in apolipoprotein E-knockout mice: Role of downregulation of CD40 and MMP-9 expression.
Liu G; Wang B; Zhang J; Jiang H; Liu F
J Ethnopharmacol; 2009 Nov; 126(2):350-4. PubMed ID: 19703533
[TBL] [Abstract][Full Text] [Related]
10. Decreased levels of lipid peroxidation-induced DNA damage in the onset of atherogenesis in apolipoprotein E deficient mice.
Godschalk RW; Albrecht C; Curfs DM; Schins RP; Bartsch H; van Schooten FJ; Nair J
Mutat Res; 2007 Aug; 621(1-2):87-94. PubMed ID: 17418875
[TBL] [Abstract][Full Text] [Related]
11. Prolonged high-fat feeding enhances aortic 18F-FDG and 99mTc-annexin A5 uptake in apolipoprotein E-deficient and wild-type C57BL/6J mice.
Zhao Y; Kuge Y; Zhao S; Strauss HW; Blankenberg FG; Tamaki N
J Nucl Med; 2008 Oct; 49(10):1707-14. PubMed ID: 18794270
[TBL] [Abstract][Full Text] [Related]
12. Endothelial overexpression of Fas ligand decreases atherosclerosis in apolipoprotein E-deficient mice.
Yang J; Sato K; Aprahamian T; Brown NJ; Hutcheson J; Bialik A; Perlman H; Walsh K
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1466-73. PubMed ID: 15178561
[TBL] [Abstract][Full Text] [Related]
13. Development of atherosclerosis in Balb/c apolipoprotein E-deficient mice.
Desai A; Zhao Y; Warren JS
Cardiovasc Pathol; 2008; 17(4):233-40. PubMed ID: 18402814
[TBL] [Abstract][Full Text] [Related]
14. Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice.
Kitayama K; Nishizawa T; Abe K; Wakabayashi K; Oda T; Inaba T; Amemiya Y
J Pharm Pharmacol; 2006 Dec; 58(12):1629-38. PubMed ID: 17331327
[TBL] [Abstract][Full Text] [Related]
15. Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo.
Veillard NR; Steffens S; Pelli G; Lu B; Kwak BR; Gerard C; Charo IF; Mach F
Circulation; 2005 Aug; 112(6):870-8. PubMed ID: 16061736
[TBL] [Abstract][Full Text] [Related]
16. Targeted disruption of the pregnancy-associated plasma protein-A gene is associated with diminished smooth muscle cell response to insulin-like growth factor-I and resistance to neointimal hyperplasia after vascular injury.
Resch ZT; Simari RD; Conover CA
Endocrinology; 2006 Dec; 147(12):5634-40. PubMed ID: 16959843
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels.
Raffai RL; Loeb SM; Weisgraber KH
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):436-41. PubMed ID: 15591220
[TBL] [Abstract][Full Text] [Related]
18. Mapping, genetic isolation, and characterization of genetic loci that determine resistance to atherosclerosis in C3H mice.
Wang SS; Shi W; Wang X; Velky L; Greenlee S; Wang MT; Drake TA; Lusis AJ
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2671-6. PubMed ID: 17916774
[TBL] [Abstract][Full Text] [Related]
19. Increased atherosclerotic lesions and Th17 in interleukin-18 deficient apolipoprotein E-knockout mice fed high-fat diet.
Pejnovic N; Vratimos A; Lee SH; Popadic D; Takeda K; Akira S; Chan WL
Mol Immunol; 2009 Nov; 47(1):37-45. PubMed ID: 19201478
[TBL] [Abstract][Full Text] [Related]
20. Effects of mutated pregnancy-associated plasma protein-a on atherosclerotic lesion development in mice.
Boldt HB; Bale LK; Resch ZT; Oxvig C; Overgaard MT; Conover CA
Endocrinology; 2013 Jan; 154(1):246-52. PubMed ID: 23161866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]